Clinical Research Directory
Browse clinical research sites, groups, and studies.
Unmasking Diabetes in Dialysis With Continuous Glucose Monitoring
Sponsor: Emory University
Summary
This study will evaluate whether Continuous Glucose Monitoring (CGM) can identify previously unrecognized diabetes and clinically significant hyperglycemia in adults with end-stage kidney disease (ESKD) receiving hemodialysis who have no known history of diabetes. Participants will wear a Libre 3 Plus CGM sensor for up to 15 days and undergo standard diabetes assessments, including fasting plasma glucose and hemoglobin. The primary objectives are to: * Determine the prevalence of previously undiagnosed diabetes among dialysis patients using OGTT criteria. * Compare CGM glucose patterns between participants with and without diabetes as determined by OGTT results.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
180
Start Date
2026-12
Completion Date
2027-11
Last Updated
2026-10-19
Healthy Volunteers
No
Interventions
Continuous Glucose Monitoring (CGM)
Participants will wear a Libre 3 Plus continuous glucose monitoring sensor to collect interstitial glucose measurements throughout the study period. CGM data will be evaluated for glucose patterns and measures of glycemic exposure.
Locations (1)
Grady Memorial Hospital
Atlanta, Georgia, United States